Structure

Prof. Dr. med. Matthias Ebert is a distinguished clinician-scientist and academic leader in the field of gastroenterology, with a particular emphasis on gastrointestinal oncology and translational medicine. Since 2011, he has served as Director of the II. Medical Clinic (Department of Gastroenterology, Hepatology, Infectious Diseases, and Nutritional Medicine) at the ...

Prof. Zhan earned his MD from Heidelberg University in 2011 and began his internal medicine training at UMM that same year. From 2013 to 2018, he conducted postdoctoral research in Signaling and Functional Genomics at the German Cancer Research Center in Heidelberg. Since 2019, he has been part of the ...

Prof. Johannes Betge is a is a physician-scientist, head of the Junior Clinical Cooperation Unit Translational Gastrointestinal Oncology and Preclinical Models at the German Cancer Research Center (DKFZ) and attending physician in gastroenterology at University Medical Center Mannheim. Prof. Betge earned his doctoral degree at Heidelberg University and completed clinical ...

Dr. Michael Zimmermann leads the Zimmermann Group at EMBL Heidelberg, where he investigates how gut microbiota metabolize drugs, nutrients, and environmental compounds—and how this shapes host physiology. Since August 2019, he has headed this research unit, supported by a prestigious ERC Starting Grant. He received his PhD in 2015 from ...

Dr. Maria Zimmermann‑Kogadeeva is a leading computational biologist and group leader in the Genome Biology Unit at EMBL in Heidelberg. After earning her PhD in 2016 from ETH Zürich’s Institute of Molecular Systems Biology, she completed postdoctoral studies at Yale—where she co-led a project revealing that gut microbes metabolize hundreds of ...

PD Dr. Nadja Meindl‑Beinker is a senior researcher at Heidelberg University’s Medical Faculty Mannheim in the Molecular Hepatology department. Since 2010, her work has centered on transforming growth factor‑β (TGF‑β) signaling and its complex roles in chronic liver disease and hepatocellular carcinoma . She earned her doctorate (Dr. rer. nat.) and completed ...

Dr. Anne Dropmann is a postdoctoral researcher specializing in molecular hepatology, with a dedicated focus on the pathogenesis and treatment of cholestatic and biliary liver diseases, including primary sclerosing cholangitis (PSC), primary biliary cholangitis (PBC), and cholangiocarcinoma (CCA). She is affiliated with the Department of Medicine II at the University ...